InvestorsHub Logo
Followers 30
Posts 5248
Boards Moderated 0
Alias Born 10/16/2012

Re: dia76ca post# 163128

Wednesday, 02/26/2014 2:38:07 PM

Wednesday, February 26, 2014 2:38:07 PM

Post# of 346474
When I read dJohn's post about "passion" I thought he nailed it! But you raise some good points too. Now, why couldn't it be argued a presentation needs both facts and passion? He, and anyone critical of Steve's performance yesterday, should not be regarded as negative. King obviously knows the science of Bavi very well. Other than Dr. Thorpe, there is really no other person with the same efforts put into the development of the Bavi-platform (although Brekken is surely catching up). Does that not deserve a presence of passion when speaking of Bavituximab and the supporting entity called Peregrine Pharmaceuticals?

Look, most here want a successful Bavi and Peregrine. Everyone has different expectations. For personal reasons, some want that "cure" to be available sooner. Some want the stock price to sky rocket and expect it to happen overnight. No one here can say the company gives out enough information. We are all seeking information. But please, don't make it sound as though you are at a higher level than the rest of us here:

Those of us who follow PPHM closely know that there is more to come!



CC to Corp: If Cotara valuation is zero I would buy it right now for $1. Cotara is difficult to place a true valuation so I assumed Peregrine would at least want to break even. But let's use your valuation in the calculation. That makes Bavi valued at $150 Million. In a world where companies with a phase II drug get bought for BILLIONS does that truly make sense?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News